NCT01211717

Brief Summary

The purpose of this study is to determine the effectiveness of the 3 Branched Chained Amino Acids (isoleucine, leucine, and valine) on treating Delayed Onset Muscle Soreness, a type of muscle pain which usually develops after exercising.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable type-2-diabetes

Timeline
Completed

Started Oct 2010

Shorter than P25 for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 29, 2010

Completed
2 days until next milestone

Study Start

First participant enrolled

October 1, 2010

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2011

Completed
Last Updated

April 22, 2011

Status Verified

April 1, 2011

Enrollment Period

5 months

First QC Date

September 28, 2010

Last Update Submit

April 21, 2011

Conditions

Keywords

Branched Chained Amino AcidsDelayed Onset Muscle SorenessDiabetesMuscle Damage

Outcome Measures

Primary Outcomes (1)

  • Measuring Pain, using the short form McGill pain questionnaire

    5 days following the initial exercise

Secondary Outcomes (1)

  • Measuring Muscle strength of the studied muscle

    5 days following the initial exercise

Study Arms (2)

Branched Chained Amino Acids

EXPERIMENTAL
Dietary Supplement: Branched Chained Amino Acids

Cellulose mix

PLACEBO COMPARATOR
Other: Cellulose Placebo mix

Interventions

Two doses of the Branched Chained Amino Acid supplement will be taken. The first dose will be taken 35 minutes before the intended exercise, and the other dose will be taken right after completing the exercise. The amount of the Branched Chained Amino Acid supplement administered to the subjects in the experimental group will vary from one person to the other but a total dose of 1 gram of BCAA per kilogram of lean body mass will be used. This dose will be divided in half and administered at the two specified occasions. The ratio of isoleucine, leucine, and valine will be 1:2.5:1 respectively

Also known as: Isoleucine, Leucine, and Valine
Branched Chained Amino Acids

The control group will also take 2 doses, 1 before the exercise, and the other after completing the exercise. This dose will be divided in half and administered at the two specified occasions.

Cellulose mix

Eligibility Criteria

Age20 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The subjects with diabetes must have been diagnosed with diabetes at least one year before the onset of the study
  • At least 6 weeks of physical inactivity in the upper body
  • BMI less than 40

You may not qualify if:

  • For the Diabetics, hemoglobin A1c levels over 13
  • Pregnant
  • Have Cardiovascular diseases
  • Have Hepatic diseases
  • Are diagnosed with Rhabdomyolysis
  • Recent upper limb injuries
  • Upper limb neuropathy
  • Blood Pressure levels over 140/90, or lower than 90/60
  • Are on High doses of alpha or beta agonist/antagonists, and take any types of NSAID's, Cox 2 inhibitors, Calcium channel blockers, Pre-Gabalin's, or Pain reducers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Loma Linda University, School of Allied Health Professions

Loma Linda, California, 92354, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Diabetes Mellitus

Interventions

IsoleucineLeucineValine

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Amino Acids, Branched-ChainAmino AcidsAmino Acids, Peptides, and ProteinsAmino Acids, Essential

Study Officials

  • Jerrold Petrofsky, Doctoral PhD

    Loma Linda University, School of Allied Health Professions

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 28, 2010

First Posted

September 29, 2010

Study Start

October 1, 2010

Primary Completion

March 1, 2011

Study Completion

April 1, 2011

Last Updated

April 22, 2011

Record last verified: 2011-04

Locations